Pharmaceutical products | Tenderlake

Pharmaceutical products

Contract Value:
EUR 3M - 3M
Notice Type:
Contract Notice
Published Date:
02 September 2022
Closing Date:
13 October 2022
Location(s):
BE251 Arr. Brugge (BE Belgium/BELGIQUE-BELGIË)
Description:
Framework agreement for the supply of Antibiotics, Antimycotics and Antivirals

See II.1.1

J01CA04 - Amoxicillin - PO

See II.2.1

J01CR02 - Amoxicillin and Enzyme Inhibitor - Syrup

See II.2.1

J01CR02 - Piperacilline in Enzymremmer - IV

See II.2.1

J01DB04 - Cefazoline - IV

See II.2.1

J01DC02 - Cefuroxim - PO

See II.2.1

J01DC02 - Cefuroxim - IV

See II.2.1

J01DD02 - Ceftazidim - IV

See II.2.1

J01DD04 - Ceftriaxon - IV

See II.2.1

J01DH02 - Meropenem - IV

See II.2.1

J01FA09 - Clarithromycine - PO

See II.2.1

J01FA10 - Azithromycine - PO

See II.2.1

J01CA04 - Amoxicillin - Soluble form

See II.2.1

J01FA10 - Azithromycin - soluble form

See II.2.1

J01FF01 - Clindamycine - PO

See II.2.1

J01FF01 - Clindamycine - IV

See II.2.1

J01GB06 - Amikacine - IV

See II.2.1

J01MA02 - Ciprofloxacin - PO

See II.2.1

J01MA02 - Ciprofloxacine - IV

See II.2.1

J01MA12 - Levofloxacine - PO (Sint-Lucas)

See II.2.1

J01MA12 - Levofloxacin - IV (Saint Luke)

See II.2.1

J01MA14 - Moxifloxacine - PO

See II.2.1

J01MA14 - Moxifloxacine - IV

See II.2.1

J01CF05 - Flucloxacilline - PO

See II.2.1

J01XA01 - Vancomycin - IV

See II.2.1

J01XX08 - Linezolide - PO

See II.2.1

J01XX08 - Linezolide - IV

See II.2.1

J02AC01 Fluconazole - PO

See II.2.1

J02AC01 - Fluconazole - IV

See II.2.1

J02AC01 - Fluconazole - Soluble form

See II.2.1

J02AC03 - Voriconazol - PO

See II.2.1

J02AC03 - Voriconazol - IV

See II.2.1

J02AC03 - Voriconazole - Soluble form

See II.2.1

J02AC04 - Posaconazole PO

See II.2.1

J01CF05 - Flucloxacilline - IV

See II.2.1

J02AX04 - Caspofungine - IV

See II.2.1

J02AX06 - Anidulafungin - IV

See II.2.1

J05AB01 - Acyclovir - PO

See II.2.1

J05AB01 - Aciclovir - IV

See II.2.1

J05AB01 - Aciclovir - IV (Sint-Lucas)

See II.2.1

J05AB11 - Valaciclovir - PO

See II.2.1

J05AB14 - Valganciclovir - PO

See II.2.1

J05AD01 - Foscarnet - IV

See II.2.1

J05AE10 - Darunavir - PO

See II.2.1

J05AF07 - Tenofovir Disoproxil - PO

See II.2.1

J01CR02 - Amoxicillin en Enzymremmer - PO

See II.2.1

J05AG01 - Nevirapine - PO

See II.2.1

J05AG03 - Efavirenz - PO

See II.2.1

J05AR02 - Lamivudine en Abacavir - PO

See II.2.1

J05AR06 - Emtricitabine, Tenofovir Disoproxil en Efavirenz - PO

See II.2.1

J05AR03 - Tenofovir Disoproxil en Emtricitabine - PO

See II.2.1

J01CR02 - Amoxicillin and Enzyme Inhibitor - IV - adult

See II.2.1

J01CR02 - Amoxicillin and Enzyme Inhibitor - IV - ped

See II.2.1

J01CR02 - Amoxicillin and Enzyme Inhibitor - soluble form - adult

See II.2.1

J01CR02 - Amoxicillin and Enzyme Inhibitor - soluble form - ped

See II.2.1

Download full details as .pdf
The Buyer:
AZ Sint-Jan Brugge-Oostende AV
CPV Code(s):
33600000 - Pharmaceutical products